ATE238073T1 - Verbesserungen für oder in bezug auf kontrastmitteln in ultraschallbilddarstellung - Google Patents

Verbesserungen für oder in bezug auf kontrastmitteln in ultraschallbilddarstellung

Info

Publication number
ATE238073T1
ATE238073T1 AT97909467T AT97909467T ATE238073T1 AT E238073 T1 ATE238073 T1 AT E238073T1 AT 97909467 T AT97909467 T AT 97909467T AT 97909467 T AT97909467 T AT 97909467T AT E238073 T1 ATE238073 T1 AT E238073T1
Authority
AT
Austria
Prior art keywords
relating
contrast agents
ultrasonic imaging
ultrasonic
imaging
Prior art date
Application number
AT97909467T
Other languages
German (de)
English (en)
Inventor
Jonny Ostensen
Morten Eriksen
Sigmund Frigstad
Pal Rongved
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9621884.7A external-priority patent/GB9621884D0/en
Priority claimed from GBGB9708239.0A external-priority patent/GB9708239D0/en
Application filed by Amersham Health As filed Critical Amersham Health As
Application granted granted Critical
Publication of ATE238073T1 publication Critical patent/ATE238073T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/928—X-ray agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/929—Ultrasound contrast agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97909467T 1996-10-21 1997-10-21 Verbesserungen für oder in bezug auf kontrastmitteln in ultraschallbilddarstellung ATE238073T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9621884.7A GB9621884D0 (en) 1996-10-21 1996-10-21 Improvements in or relating to contrast agents
GBGB9708239.0A GB9708239D0 (en) 1997-04-23 1997-04-23 Improvements in or relating to contrast agents
PCT/GB1997/002898 WO1998017324A2 (en) 1996-10-21 1997-10-21 Improvements in or relating to contrast agents

Publications (1)

Publication Number Publication Date
ATE238073T1 true ATE238073T1 (de) 2003-05-15

Family

ID=26310262

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02078777T ATE381353T1 (de) 1996-10-21 1997-10-21 Verbesserungen in oder an kontrastmitteln
AT97909467T ATE238073T1 (de) 1996-10-21 1997-10-21 Verbesserungen für oder in bezug auf kontrastmitteln in ultraschallbilddarstellung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT02078777T ATE381353T1 (de) 1996-10-21 1997-10-21 Verbesserungen in oder an kontrastmitteln

Country Status (26)

Country Link
US (3) US6375931B2 (enExample)
EP (2) EP1007100B1 (enExample)
JP (1) JP2001502349A (enExample)
KR (1) KR20000052652A (enExample)
CN (1) CN1106859C (enExample)
AP (1) AP885A (enExample)
AT (2) ATE381353T1 (enExample)
AU (1) AU745047B2 (enExample)
BG (1) BG103402A (enExample)
BR (1) BR9712370A (enExample)
CA (1) CA2269319C (enExample)
CZ (1) CZ140999A3 (enExample)
DE (2) DE69721331T2 (enExample)
EE (1) EE03749B1 (enExample)
ES (1) ES2197336T3 (enExample)
HU (1) HU224218B1 (enExample)
ID (1) ID21681A (enExample)
IL (1) IL129423A (enExample)
MX (1) MXPA99003664A (enExample)
NO (1) NO991869L (enExample)
NZ (1) NZ335265A (enExample)
PL (1) PL332820A1 (enExample)
RU (1) RU2204415C2 (enExample)
SK (1) SK283210B6 (enExample)
TR (1) TR199901544T2 (enExample)
WO (1) WO1998017324A2 (enExample)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US6774278B1 (en) 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
AU725693B2 (en) * 1996-03-12 2000-10-19 Board Of Regents Of The University Of Nebraska, The Targeted site specific drug delivery compositions and method of use
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
DK1323434T3 (da) * 1996-09-11 2007-11-12 Bristol Myers Squibb Medical I Fremgangsmåde til diagnostisk billeddannelse af nyreregioner under anvendelse af et kontrastmiddel og en vasodilator
AP885A (en) * 1996-10-21 2000-11-03 Nycomed Imaging As Ultrasonic visualisation using a gas containing contrast agent.
GB9708246D0 (en) * 1997-04-24 1997-06-18 Nycomed Imaging As Improvements in or relating to ultrasound imaging
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
GB9717588D0 (en) * 1997-08-19 1997-10-22 Nycomed Imaging As Improvements in or relating to contrast agents
WO1999020312A1 (en) 1997-10-21 1999-04-29 Nycomed Imaging As Ultrasound imaging with contrast agent targeted to microvasculature and a vasodilator drug
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE19805012A1 (de) * 1998-02-07 1999-08-12 Thomas Gieselmann Kontrastmittel zur Verwendung als Diagnostikum bei bildgebenden Verfahren sowie seine Herstellung
GB9808582D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
US20040170564A1 (en) * 1998-04-22 2004-09-02 Roald Skurtveit Ultrasound contrast agent dispersions comprising gas and destabilising agent
GB9808599D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or realting to contrast agents
GB9808581D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
GB9813568D0 (en) * 1998-06-23 1998-08-19 Nycomed Imaging As Improvements in or relating to cardiac imaging
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
NO20010234D0 (no) * 2001-01-12 2001-01-12 Nycomed Imaging As Perfusjon avbildningsbilde
US7179449B2 (en) * 2001-01-30 2007-02-20 Barnes-Jewish Hospital Enhanced ultrasound detection with temperature-dependent contrast agents
DE10115740A1 (de) * 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
US20080193490A1 (en) * 2002-02-14 2008-08-14 Andreas Hirsch Use of Carbon Nanotube for Drug Delivery
US20040166152A1 (en) * 2002-02-14 2004-08-26 Andreas Hirsch Use of buckysome or carbon nanotube for drug delivery
WO2004065621A1 (en) 2002-03-01 2004-08-05 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
EP1572724A4 (en) 2002-03-01 2007-03-14 Dyax Corp KDR AND VEGF / KDR BINDING SPEPTIDES AND THEIR USE IN DIAGNOSIS AND THERAPY
US20090060992A1 (en) * 2002-05-08 2009-03-05 University Of Central Florida Research Foundation, Inc., Preparation of magneto-vesicles with DOPE/DDAB layers
AU2003247376A1 (en) * 2002-05-17 2003-12-02 Case Western Reserve University Double contrast technique for mri-guided vascular interventions
AU2003270689A1 (en) * 2002-09-19 2004-04-08 New York University Control of nitric oxide bioactivity by perfluorocarbons
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
ES2431520T3 (es) * 2003-01-25 2013-11-26 Seno Medical Instruments, Inc. Procedimiento de formación de imágenes optoacústicas de contraste elevado utilizando nanopartículas no esféricas
US20040146461A1 (en) * 2003-01-29 2004-07-29 Vincenzo Giuliano Oral contrast media composition for computerized axial tomographic examinations and method
US7378081B2 (en) 2003-01-29 2008-05-27 Vincon Research Enterprises, Llc Composition and method for direct visualization of the human appendix
KR101201657B1 (ko) * 2003-01-31 2012-11-14 가부시키 가이샤 오오쯔카 세이야쿠 고우죠우 유전가열에 의한 암치료법에 사용하는 보조제 및 암치료법
AU2004210221B2 (en) * 2003-02-04 2008-11-20 Bracco Suisse S.A. Ultrasound contrast agents and process for the preparation thereof
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
PT2949658T (pt) 2003-03-03 2018-10-18 Bracco Suisse Sa Péptidos que ligam especificamente o recetor de hgf (cmet) e utilizações dos mesmos
US20040258760A1 (en) * 2003-03-20 2004-12-23 Wheatley Margaret A. Isolated nanocapsule populations and surfactant-stabilized microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production
US20080299047A1 (en) * 2003-07-31 2008-12-04 National Cheng Kung University Method for preparation of water-soluble and dispersed iron oxide nanoparticles and application thereof
SE526838C2 (sv) * 2003-11-27 2005-11-08 Xcounter Ab Undersökningsmetod och anordning för detektion av joniserande strålning
JP5513708B2 (ja) * 2003-12-22 2014-06-04 ブラッコ・シュイス・ソシエテ・アノニム 造影イメージング用の気体封入マイクロベシクル・アセンブリー
RU2346693C2 (ru) * 2004-01-27 2009-02-20 Си Ви Терапьютикс, Инк. Визуализация перфузии миокарда с использованием агонистов аденозиновых рецепторов
AU2005232441B2 (en) * 2004-04-13 2010-11-11 Cambridge Biostability Limited Liquids containing suspended glass particles
US8012457B2 (en) * 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
CN103120799A (zh) 2004-08-18 2013-05-29 博莱科瑞士股份有限公司 用于反差成像的充气微泡组合物
US8034222B2 (en) * 2004-10-26 2011-10-11 The Regents Of The University Of California Conducting polymer nanowire sensors
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
US20070167862A1 (en) * 2005-11-29 2007-07-19 Lopez George A Cardiac output measurement devices and methods
CA2947346C (en) 2005-12-09 2018-07-24 Bracco Suisse Sa Targeting vector-phospholipid conjugates
MY150133A (en) * 2006-02-28 2013-11-29 Du Pont Azeotropic compositions comprising fluorinated compounds for cleaning applications
CN100400105C (zh) * 2006-05-11 2008-07-09 上海交通大学 水性基质的消化道ct阴性造影剂及其制备方法
JP4279328B2 (ja) * 2007-05-07 2009-06-17 株式会社日立製作所 超音波撮像システム
RU2387365C2 (ru) * 2007-08-15 2010-04-27 Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО НижГМА Росздрава) Способ исследования состояния кожи методом оптической когерентной томографии
KR100957560B1 (ko) * 2007-10-18 2010-05-11 한국생명공학연구원 양자점 나노입자를 함유한 퍼플루오르카본 나노에멀젼 및그 제조방법
RU2367443C1 (ru) * 2008-02-28 2009-09-20 Общество с ограниченной ответственностью "Битеп" Средство на основе природных фосфолипидов
GB0811856D0 (en) * 2008-06-27 2008-07-30 Ucl Business Plc Magnetic microbubbles, methods of preparing them and their uses
US8908939B2 (en) * 2008-09-30 2014-12-09 Koninklijke Philips N.V. Perfusion imaging
US9072490B2 (en) * 2010-12-20 2015-07-07 Toshiba Medical Systems Corporation Image processing apparatus and image processing method
ITRM20110022A1 (it) * 2011-01-21 2012-07-22 Gaio Paradossi Metodo per la preparazione di microbolle comprendenti un agente di contrasto
RU2454174C2 (ru) * 2011-03-16 2012-06-27 Федеральное государственное учреждение "Московский научно-исследовательский онкологический институт им. П.А. Герцена" Министерства здравоохранения и социального развития Российской Федерации (ФГУ "МНИОИ им. П.А. Герцена" Минздравсоцразвития России) Способ диагностики опухолей шейки матки
RU2453270C1 (ru) * 2011-03-31 2012-06-20 Федеральное государственное учреждение "Московский научно-исследовательский онкологический институт им. П.А. Герцена Министерства здравоохранения и социального развития Российской Федерации" (ФГУ "МНИОИ им. П.А. Герцена" Минздравсоцразвития России) Способ исследования терминального отдела толстой кишки
RU2485976C2 (ru) * 2011-05-17 2013-06-27 Государственное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГОУ ВПО СибГМУ Минздравсоцразвития России) Контрастное средство для ультразвуковой визуализации
AU2013255952B2 (en) * 2012-04-30 2018-04-12 Ge Healthcare As Method for filling a container with a foamable composition
KR102139393B1 (ko) * 2012-06-26 2020-07-29 지이 헬스케어 에이에스 기체 미세기포를 포함하는 조성물의 제조
CN103100093B (zh) * 2013-01-23 2015-05-06 中山大学附属第三医院 一种负载小干扰rna的纳米级脂质微泡超声造影剂及制备方法
HRP20221118T1 (hr) * 2013-09-27 2022-12-23 Exact Therapeutics As Dostava lijekova posredovana ultrazvukom
EP3240579B1 (en) 2014-12-31 2022-07-27 Lantheus Medical Imaging, Inc. Lipid-encapsulated gas microsphere compositions and related methods
WO2017192910A2 (en) 2016-05-04 2017-11-09 Lantheus Medical Imaging, Inc. Methods and devices for preparation of ultrasound contrast agents
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
GB201821049D0 (en) * 2018-12-21 2019-02-06 Ge Healthcare As Ultrasound contrast agent and methods for use therof
US11642172B2 (en) * 2019-03-05 2023-05-09 Biosense Webster (Israel) Ltd. Showing catheter in brain
US12005130B2 (en) 2019-10-16 2024-06-11 Agitated Solutions Inc. Generating microbubbles for bubble studies
US11191888B1 (en) 2020-05-18 2021-12-07 Agitated Solutions Inc. Syringe-based microbubble generator
RU2744825C1 (ru) * 2020-06-03 2021-03-16 Федеральное государственное бюджетное образовательное учреждение высшего образования "Смоленский государственный медицинский университет" министерства здравоохранения Российской Федерации Способ определения времени течения артериальной фазы эхоконтрастирования печени, почек и селезенки
US20220079499A1 (en) * 2020-09-14 2022-03-17 Biosense Webster (Israel) Ltd. Identification of ablation gaps

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5773024A (en) * 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5117830A (en) * 1990-11-08 1992-06-02 Whitby Research, Inc. Method of determining viability of tissue
DE69427185T2 (de) * 1993-01-25 2001-12-06 Sonus Pharmaceutical, Inc. Phase-Stift Kolloide zur Verwendung als Ultraschallkontrastmittel
US5362478A (en) * 1993-03-26 1994-11-08 Vivorx Pharmaceuticals, Inc. Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
ATE281183T1 (de) * 1993-07-30 2004-11-15 Alliance Pharma Stabilisierte mikrogasblaeschen-zusammensetzungen für echografie
US5798091A (en) * 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
DE4406474A1 (de) * 1994-02-23 1995-08-24 Schering Ag Gas enthaltende Mikropartikel, diese enthaltende Mittel, deren Verwendung in der Ultraschalldiagnostik, sowie Verfahren zur Herstellung der Partikel und Mittel
GB9423419D0 (en) * 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US5560364A (en) * 1995-05-12 1996-10-01 The Board Of Regents Of The University Of Nebraska Suspended ultra-sound induced microbubble cavitation imaging
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
AP885A (en) * 1996-10-21 2000-11-03 Nycomed Imaging As Ultrasonic visualisation using a gas containing contrast agent.
US6054118A (en) * 1997-01-22 2000-04-25 Nycomed Imaging As Contrast agents comprising two types of gas-containing microparticles

Also Published As

Publication number Publication date
BG103402A (bg) 2000-01-31
US6783752B2 (en) 2004-08-31
HUP0000282A3 (en) 2001-09-28
AP9901511A0 (en) 1999-06-30
DE69721331D1 (de) 2003-05-28
EE03749B1 (et) 2002-06-17
ES2197336T3 (es) 2004-01-01
CA2269319C (en) 2008-03-18
DE69738406D1 (de) 2008-01-31
CA2269319A1 (en) 1998-04-30
EP1264604A3 (en) 2004-03-10
SK52099A3 (en) 2000-01-18
EP1007100A2 (en) 2000-06-14
CN1106859C (zh) 2003-04-30
IL129423A (en) 2003-01-12
NZ335265A (en) 2000-07-28
WO1998017324A3 (en) 1998-06-25
BR9712370A (pt) 1999-08-31
DE69738406T2 (de) 2008-12-04
TR199901544T2 (xx) 1999-09-21
HUP0000282A2 (hu) 2000-05-28
JP2001502349A (ja) 2001-02-20
DE69721331T2 (de) 2004-05-06
US20040141921A1 (en) 2004-07-22
CN1238699A (zh) 1999-12-15
ATE381353T1 (de) 2008-01-15
US20050118104A1 (en) 2005-06-02
MXPA99003664A (es) 2002-06-11
IL129423A0 (en) 2000-02-17
PL332820A1 (en) 1999-10-11
NO991869D0 (no) 1999-04-19
CZ140999A3 (cs) 1999-09-15
AP885A (en) 2000-11-03
US20010002993A1 (en) 2001-06-07
EE9900158A (et) 1999-12-15
ID21681A (id) 1999-07-08
RU2204415C2 (ru) 2003-05-20
AU745047B2 (en) 2002-03-07
AU4714797A (en) 1998-05-15
SK283210B6 (sk) 2003-03-04
HU224218B1 (hu) 2005-06-28
NO991869L (no) 1999-06-02
KR20000052652A (ko) 2000-08-25
EP1264604B1 (en) 2007-12-19
EP1007100B1 (en) 2003-04-23
EP1264604A2 (en) 2002-12-11
WO1998017324A2 (en) 1998-04-30
US6375931B2 (en) 2002-04-23

Similar Documents

Publication Publication Date Title
ATE238073T1 (de) Verbesserungen für oder in bezug auf kontrastmitteln in ultraschallbilddarstellung
ATE238072T1 (de) Verbesserungen an (oder im bezug auf) kontrastmittel
DE19500856C2 (de) Ultraschall-Diagnosesystem
DE69503008D1 (de) Absorbierende zusammengesetzte Unterlage für Haustiere
DE69529307D1 (de) Ultraschall-Diagnose- und Behandlungssystem
NO954185D0 (no) Tordensky-observasjonssystem
DE69739460D1 (de) Verbesserungen in oder sich beziehend auf einer atm-vermittlungsstelle
FI963075A7 (fi) Vahvistettu mikrodialyysikoetin
DE69511310D1 (de) Siebausbildung für Mähdrescher
DE69533379D1 (de) Verbesserungen in oder in Bezug auf Elektroden für LSI
IL112657A0 (en) Improvements in or relating to contrast agents
DE69739652D1 (de) Verbesserungen in oder sich beziehend auf einer atm-vermittlungsstelle
FI954967L (fi) Diagnostinen kuvausaine
FI962930A7 (fi) Parannuksia sakeusanturissa tai siihen liittyen
NO993438D0 (no) Kontrastmidler for ultralyd
DE59811963D1 (de) Exoprothese für das menschliche kniegelenk
DE69505237D1 (de) Schwimmer für die fischerei
ATA122895A (de) Reinigungssegment für rohrleitungen
UA1031S (uk) Комплекс ультразвуковий діагностичний
GB9622368D0 (en) Improvements in or relating to diagnostic/therapeutic agents
DE69327161D1 (de) Ultraschallgerät für Gesundheits- und Schönheitsbehandlung
GB9700698D0 (en) Improvements in or relating to diagnostic/therapeutics agents
KR950022759U (ko) 진단용 탐침
GB9622365D0 (en) Improvements in or relating to diagnostic/therapeutic agents
GB9622367D0 (en) Improvements in or relating to diagnostic/therapeutic agents

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties